nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—PPP3CA—Cyclosporine—focal segmental glomerulosclerosis	0.403	0.642	CbGbCtD
Tacrolimus—ALB—focal segmental glomerulosclerosis	0.204	1	CbGaD
Tacrolimus—FKBP1A—Cyclosporine—focal segmental glomerulosclerosis	0.167	0.267	CbGbCtD
Tacrolimus—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0162	0.0258	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0162	0.0258	CbGbCtD
Tacrolimus—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0194	CbGbCtD
Tacrolimus—PPP3CA—nephron—focal segmental glomerulosclerosis	0.0104	0.317	CbGeAlD
Tacrolimus—Polyomavirus-associated nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00804	0.0704	CcSEcCtD
Tacrolimus—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.00792	0.0126	CbGbCtD
Tacrolimus—Graft loss—Cyclosporine—focal segmental glomerulosclerosis	0.00534	0.0468	CcSEcCtD
Tacrolimus—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.00756	CbGbCtD
Tacrolimus—Hypotrichosis—Cyclosporine—focal segmental glomerulosclerosis	0.00408	0.0357	CcSEcCtD
Tacrolimus—Blindness cortical—Cyclosporine—focal segmental glomerulosclerosis	0.00408	0.0357	CcSEcCtD
Tacrolimus—ABCA5—nephron tubule—focal segmental glomerulosclerosis	0.00333	0.101	CbGeAlD
Tacrolimus—Thrombotic microangiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.0269	CcSEcCtD
Tacrolimus—ABCA5—cortex of kidney—focal segmental glomerulosclerosis	0.00285	0.0867	CbGeAlD
Tacrolimus—X-linked lymphoproliferative syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.0249	CcSEcCtD
Tacrolimus—Progressive multifocal leukoencephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.0249	CcSEcCtD
Tacrolimus—Lymphoproliferative disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.0249	CcSEcCtD
Tacrolimus—Posterior reversible encephalopathy syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.0205	CcSEcCtD
Tacrolimus—PPP3CA—nephron tubule—focal segmental glomerulosclerosis	0.00225	0.0684	CbGeAlD
Tacrolimus—Consciousness abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0194	CcSEcCtD
Tacrolimus—PPP3CA—kidney—focal segmental glomerulosclerosis	0.00198	0.0601	CbGeAlD
Tacrolimus—PPP3CA—cortex of kidney—focal segmental glomerulosclerosis	0.00193	0.0586	CbGeAlD
Tacrolimus—Function kidney decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.0154	CcSEcCtD
Tacrolimus—Haemolytic uraemic syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.0154	CcSEcCtD
Tacrolimus—Septicemia—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.0148	CcSEcCtD
Tacrolimus—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00157	0.0478	CbGeAlD
Tacrolimus—Acute respiratory distress syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.0129	CcSEcCtD
Tacrolimus—Tendon disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.0129	CcSEcCtD
Tacrolimus—MTOR—kidney—focal segmental glomerulosclerosis	0.00146	0.0444	CbGeAlD
Tacrolimus—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.00139	0.0651	CbGpPWpGaD
Tacrolimus—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00135	0.0409	CbGeAlD
Tacrolimus—Thrombotic thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0118	CcSEcCtD
Tacrolimus—FKBP1A—kidney—focal segmental glomerulosclerosis	0.00131	0.0399	CbGeAlD
Tacrolimus—FKBP1A—cortex of kidney—focal segmental glomerulosclerosis	0.00128	0.0389	CbGeAlD
Tacrolimus—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0112	CcSEcCtD
Tacrolimus—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0109	CcSEcCtD
Tacrolimus—Nephrotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.0106	CcSEcCtD
Tacrolimus—Non-Hodgkin's lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00965	CcSEcCtD
Tacrolimus—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00965	CcSEcCtD
Tacrolimus—Lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00965	CcSEcCtD
Tacrolimus—Renal tubular necrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00944	CcSEcCtD
Tacrolimus—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00924	CcSEcCtD
Tacrolimus—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.000833	0.0073	CcSEcCtD
Tacrolimus—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.000833	0.0073	CcSEcCtD
Tacrolimus—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.000833	0.0073	CcSEcCtD
Tacrolimus—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000821	0.00719	CcSEcCtD
Tacrolimus—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000808	0.00708	CcSEcCtD
Tacrolimus—PPP3CA—Physiological and Pathological Hypertrophy  of the Heart—EDN1—focal segmental glomerulosclerosis	0.000799	0.0373	CbGpPWpGaD
Tacrolimus—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.000796	0.00697	CcSEcCtD
Tacrolimus—MTOR—EGFR-dependent Endothelin signaling events—EDN1—focal segmental glomerulosclerosis	0.000789	0.0369	CbGpPWpGaD
Tacrolimus—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000713	0.00624	CcSEcCtD
Tacrolimus—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00067	0.00587	CcSEcCtD
Tacrolimus—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.00067	0.00587	CcSEcCtD
Tacrolimus—PPP3CA—Physiological and Pathological Hypertrophy  of the Heart—AGT—focal segmental glomerulosclerosis	0.000663	0.031	CbGpPWpGaD
Tacrolimus—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.0058	CcSEcCtD
Tacrolimus—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.0058	CcSEcCtD
Tacrolimus—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000651	0.0198	CbGeAlD
Tacrolimus—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.000633	0.00554	CcSEcCtD
Tacrolimus—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.000612	0.00536	CcSEcCtD
Tacrolimus—MTOR—IFN-gamma pathway—PIAS1—focal segmental glomerulosclerosis	0.00061	0.0285	CbGpPWpGaD
Tacrolimus—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.00531	CcSEcCtD
Tacrolimus—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000599	0.00525	CcSEcCtD
Tacrolimus—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000593	0.0052	CcSEcCtD
Tacrolimus—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000593	0.0052	CcSEcCtD
Tacrolimus—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.000587	0.00514	CcSEcCtD
Tacrolimus—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.00504	CcSEcCtD
Tacrolimus—PPP3CA—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.000573	0.0268	CbGpPWpGaD
Tacrolimus—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000573	0.0174	CbGeAlD
Tacrolimus—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000558	0.0169	CbGeAlD
Tacrolimus—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.000556	0.026	CbGpPWpGaD
Tacrolimus—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.000554	0.00485	CcSEcCtD
Tacrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	0.000544	0.0254	CbGpPWpGaD
Tacrolimus—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.000544	0.00476	CcSEcCtD
Tacrolimus—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.000544	0.00476	CcSEcCtD
Tacrolimus—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000539	0.00472	CcSEcCtD
Tacrolimus—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000534	0.00468	CcSEcCtD
Tacrolimus—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.000511	0.00448	CcSEcCtD
Tacrolimus—MTOR—Interferon type I signaling pathways—PIAS1—focal segmental glomerulosclerosis	0.000509	0.0238	CbGpPWpGaD
Tacrolimus—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.000507	0.00444	CcSEcCtD
Tacrolimus—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.000498	0.00436	CcSEcCtD
Tacrolimus—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.000494	0.00433	CcSEcCtD
Tacrolimus—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000494	0.00433	CcSEcCtD
Tacrolimus—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00049	0.00429	CcSEcCtD
Tacrolimus—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00049	0.00429	CcSEcCtD
Tacrolimus—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.000486	0.00426	CcSEcCtD
Tacrolimus—FKBP1A—TGF-beta receptor signaling—CTGF—focal segmental glomerulosclerosis	0.000483	0.0226	CbGpPWpGaD
Tacrolimus—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.000457	0.00401	CcSEcCtD
Tacrolimus—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.000457	0.00401	CcSEcCtD
Tacrolimus—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.000451	0.00395	CcSEcCtD
Tacrolimus—FKBP1A—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.000445	0.0208	CbGpPWpGaD
Tacrolimus—PPP3CA—BCR signaling pathway—CD79A—focal segmental glomerulosclerosis	0.00044	0.0206	CbGpPWpGaD
Tacrolimus—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000438	0.00384	CcSEcCtD
Tacrolimus—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.00381	CcSEcCtD
Tacrolimus—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00043	0.0131	CbGeAlD
Tacrolimus—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000423	0.00371	CcSEcCtD
Tacrolimus—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.000423	0.00371	CcSEcCtD
Tacrolimus—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000423	0.00371	CcSEcCtD
Tacrolimus—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000423	0.00371	CcSEcCtD
Tacrolimus—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.000418	0.00366	CcSEcCtD
Tacrolimus—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.00363	CcSEcCtD
Tacrolimus—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.00363	CcSEcCtD
Tacrolimus—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000412	0.00361	CcSEcCtD
Tacrolimus—PPP3CA—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.000411	0.0192	CbGpPWpGaD
Tacrolimus—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.000404	0.00354	CcSEcCtD
Tacrolimus—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000404	0.00354	CcSEcCtD
Tacrolimus—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.000404	0.00354	CcSEcCtD
Tacrolimus—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000392	0.00343	CcSEcCtD
Tacrolimus—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.000385	0.00337	CcSEcCtD
Tacrolimus—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.000385	0.00337	CcSEcCtD
Tacrolimus—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000378	0.00331	CcSEcCtD
Tacrolimus—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.000374	0.00327	CcSEcCtD
Tacrolimus—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.000372	0.00325	CcSEcCtD
Tacrolimus—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.000372	0.00325	CcSEcCtD
Tacrolimus—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.000367	0.00322	CcSEcCtD
Tacrolimus—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.0032	CcSEcCtD
Tacrolimus—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.000363	0.00318	CcSEcCtD
Tacrolimus—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000361	0.00316	CcSEcCtD
Tacrolimus—PPP3CA—G Protein Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00036	0.0168	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFB1—focal segmental glomerulosclerosis	0.000357	0.0167	CbGpPWpGaD
Tacrolimus—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.000354	0.0031	CcSEcCtD
Tacrolimus—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.000352	0.00308	CcSEcCtD
Tacrolimus—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.000352	0.00308	CcSEcCtD
Tacrolimus—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.000348	0.00305	CcSEcCtD
Tacrolimus—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000346	0.0105	CbGeAlD
Tacrolimus—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.000336	0.00294	CcSEcCtD
Tacrolimus—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.00292	CcSEcCtD
Tacrolimus—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.00292	CcSEcCtD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000329	0.0154	CbGpPWpGaD
Tacrolimus—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000327	0.00287	CcSEcCtD
Tacrolimus—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.00281	CcSEcCtD
Tacrolimus—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.00276	CcSEcCtD
Tacrolimus—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.00273	CcSEcCtD
Tacrolimus—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.00273	CcSEcCtD
Tacrolimus—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.00272	CcSEcCtD
Tacrolimus—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.00272	CcSEcCtD
Tacrolimus—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.000309	0.00271	CcSEcCtD
Tacrolimus—PPP3CA—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.000309	0.0144	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—SPP1—focal segmental glomerulosclerosis	0.000308	0.0144	CbGpPWpGaD
Tacrolimus—ABCB1—kidney—focal segmental glomerulosclerosis	0.000304	0.00924	CbGeAlD
Tacrolimus—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000304	0.00266	CcSEcCtD
Tacrolimus—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—EDN1—focal segmental glomerulosclerosis	0.000303	0.0142	CbGpPWpGaD
Tacrolimus—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.000299	0.00262	CcSEcCtD
Tacrolimus—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000297	0.0026	CcSEcCtD
Tacrolimus—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000296	0.009	CbGeAlD
Tacrolimus—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000296	0.00259	CcSEcCtD
Tacrolimus—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000294	0.00257	CcSEcCtD
Tacrolimus—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.000292	0.00256	CcSEcCtD
Tacrolimus—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000289	0.00253	CcSEcCtD
Tacrolimus—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000287	0.00252	CcSEcCtD
Tacrolimus—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000286	0.0134	CbGpPWpGaD
Tacrolimus—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00251	CcSEcCtD
Tacrolimus—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00251	CcSEcCtD
Tacrolimus—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000279	0.00245	CcSEcCtD
Tacrolimus—MTOR—Regulation of Telomerase—WT1—focal segmental glomerulosclerosis	0.000279	0.013	CbGpPWpGaD
Tacrolimus—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00241	CcSEcCtD
Tacrolimus—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00241	CcSEcCtD
Tacrolimus—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000265	0.00232	CcSEcCtD
Tacrolimus—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.00229	CcSEcCtD
Tacrolimus—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000256	0.00224	CcSEcCtD
Tacrolimus—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000252	0.00221	CcSEcCtD
Tacrolimus—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—AGT—focal segmental glomerulosclerosis	0.000252	0.0118	CbGpPWpGaD
Tacrolimus—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000252	0.0022	CcSEcCtD
Tacrolimus—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.00217	CcSEcCtD
Tacrolimus—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000246	0.00216	CcSEcCtD
Tacrolimus—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000243	0.00213	CcSEcCtD
Tacrolimus—FKBP1A—ALK1 signaling events—TGFB1—focal segmental glomerulosclerosis	0.000242	0.0113	CbGpPWpGaD
Tacrolimus—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000241	0.00211	CcSEcCtD
Tacrolimus—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000237	0.00207	CcSEcCtD
Tacrolimus—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000235	0.011	CbGpPWpGaD
Tacrolimus—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000235	0.00206	CcSEcCtD
Tacrolimus—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000232	0.00203	CcSEcCtD
Tacrolimus—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000226	0.00198	CcSEcCtD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000223	0.0104	CbGpPWpGaD
Tacrolimus—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.00195	CcSEcCtD
Tacrolimus—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00022	0.00192	CcSEcCtD
Tacrolimus—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000218	0.00191	CcSEcCtD
Tacrolimus—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000218	0.00191	CcSEcCtD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000217	0.0102	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000217	0.0101	CbGpPWpGaD
Tacrolimus—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000217	0.0019	CcSEcCtD
Tacrolimus—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.00189	CcSEcCtD
Tacrolimus—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.00189	CcSEcCtD
Tacrolimus—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.00188	CcSEcCtD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—SERPINE1—focal segmental glomerulosclerosis	0.000214	0.00998	CbGpPWpGaD
Tacrolimus—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00186	CcSEcCtD
Tacrolimus—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00185	CcSEcCtD
Tacrolimus—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000211	0.00185	CcSEcCtD
Tacrolimus—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000211	0.00185	CcSEcCtD
Tacrolimus—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00021	0.00184	CcSEcCtD
Tacrolimus—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00021	0.00184	CcSEcCtD
Tacrolimus—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000209	0.00183	CcSEcCtD
Tacrolimus—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000209	0.00183	CcSEcCtD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000207	0.00967	CbGpPWpGaD
Tacrolimus—MTOR—TSH signaling pathway—GNAQ—focal segmental glomerulosclerosis	0.000207	0.00966	CbGpPWpGaD
Tacrolimus—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000205	0.0018	CcSEcCtD
Tacrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFB1—focal segmental glomerulosclerosis	0.000205	0.00958	CbGpPWpGaD
Tacrolimus—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.00178	CcSEcCtD
Tacrolimus—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000203	0.00178	CcSEcCtD
Tacrolimus—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.00177	CcSEcCtD
Tacrolimus—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.0017	CcSEcCtD
Tacrolimus—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.0017	CcSEcCtD
Tacrolimus—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00169	CcSEcCtD
Tacrolimus—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00169	CcSEcCtD
Tacrolimus—MTOR—Signaling by PDGF—COL4A4—focal segmental glomerulosclerosis	0.000192	0.00899	CbGpPWpGaD
Tacrolimus—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.00168	CcSEcCtD
Tacrolimus—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.00168	CcSEcCtD
Tacrolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.000192	0.00895	CbGpPWpGaD
Tacrolimus—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00167	CcSEcCtD
Tacrolimus—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00019	0.00166	CcSEcCtD
Tacrolimus—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00166	CcSEcCtD
Tacrolimus—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000186	0.00163	CcSEcCtD
Tacrolimus—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00018	0.00158	CcSEcCtD
Tacrolimus—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000179	0.00157	CcSEcCtD
Tacrolimus—MTOR—Signaling by PDGF—COL4A1—focal segmental glomerulosclerosis	0.000177	0.00826	CbGpPWpGaD
Tacrolimus—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000175	0.00154	CcSEcCtD
Tacrolimus—PPP3CA—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000175	0.00818	CbGpPWpGaD
Tacrolimus—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000174	0.00153	CcSEcCtD
Tacrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SERPINE1—focal segmental glomerulosclerosis	0.000174	0.00811	CbGpPWpGaD
Tacrolimus—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000173	0.00152	CcSEcCtD
Tacrolimus—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000173	0.00151	CcSEcCtD
Tacrolimus—PPP3CA—Cardiac Hypertrophic Response—TGFB1—focal segmental glomerulosclerosis	0.000171	0.00801	CbGpPWpGaD
Tacrolimus—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000171	0.0015	CcSEcCtD
Tacrolimus—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.00148	CcSEcCtD
Tacrolimus—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000168	0.00147	CcSEcCtD
Tacrolimus—MTOR—IL4-mediated signaling events—CD40LG—focal segmental glomerulosclerosis	0.000167	0.00778	CbGpPWpGaD
Tacrolimus—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000166	0.00145	CcSEcCtD
Tacrolimus—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.00145	CcSEcCtD
Tacrolimus—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.00144	CcSEcCtD
Tacrolimus—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.00143	CcSEcCtD
Tacrolimus—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000162	0.00142	CcSEcCtD
Tacrolimus—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000159	0.00139	CcSEcCtD
Tacrolimus—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000158	0.00138	CcSEcCtD
Tacrolimus—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000156	0.00731	CbGpPWpGaD
Tacrolimus—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000156	0.00137	CcSEcCtD
Tacrolimus—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000155	0.00136	CcSEcCtD
Tacrolimus—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000155	0.00135	CcSEcCtD
Tacrolimus—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000152	0.00133	CcSEcCtD
Tacrolimus—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000151	0.00132	CcSEcCtD
Tacrolimus—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000151	0.00132	CcSEcCtD
Tacrolimus—MTOR—SREBP signalling—LPL—focal segmental glomerulosclerosis	0.00015	0.00701	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—COL4A3—focal segmental glomerulosclerosis	0.000149	0.00698	CbGpPWpGaD
Tacrolimus—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00129	CcSEcCtD
Tacrolimus—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00128	CcSEcCtD
Tacrolimus—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000145	0.00127	CcSEcCtD
Tacrolimus—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000144	0.00671	CbGpPWpGaD
Tacrolimus—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000143	0.00125	CcSEcCtD
Tacrolimus—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000143	0.00125	CcSEcCtD
Tacrolimus—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000143	0.00125	CcSEcCtD
Tacrolimus—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000143	0.00125	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000142	0.00125	CcSEcCtD
Tacrolimus—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000141	0.00124	CcSEcCtD
Tacrolimus—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00014	0.00123	CcSEcCtD
Tacrolimus—FKBP1A—TGF-beta receptor signaling—TGFB1—focal segmental glomerulosclerosis	0.000139	0.00649	CbGpPWpGaD
Tacrolimus—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000138	0.00121	CcSEcCtD
Tacrolimus—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000137	0.0012	CcSEcCtD
Tacrolimus—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000137	0.0012	CcSEcCtD
Tacrolimus—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000136	0.00119	CcSEcCtD
Tacrolimus—FKBP1A—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000136	0.00634	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—TGFB1—focal segmental glomerulosclerosis	0.000135	0.0063	CbGpPWpGaD
Tacrolimus—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000135	0.00118	CcSEcCtD
Tacrolimus—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000134	0.00118	CcSEcCtD
Tacrolimus—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000133	0.00117	CcSEcCtD
Tacrolimus—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000133	0.00116	CcSEcCtD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—EDN1—focal segmental glomerulosclerosis	0.000132	0.00618	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—NOS2—focal segmental glomerulosclerosis	0.000131	0.00613	CbGpPWpGaD
Tacrolimus—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000131	0.00115	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.00013	0.00607	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000125	0.0011	CcSEcCtD
Tacrolimus—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000124	0.00109	CcSEcCtD
Tacrolimus—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000123	0.00108	CcSEcCtD
Tacrolimus—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000122	0.00107	CcSEcCtD
Tacrolimus—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—focal segmental glomerulosclerosis	0.000122	0.00571	CbGpPWpGaD
Tacrolimus—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000122	0.00107	CcSEcCtD
Tacrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—focal segmental glomerulosclerosis	0.000121	0.00567	CbGpPWpGaD
Tacrolimus—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000121	0.00106	CcSEcCtD
Tacrolimus—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000119	0.00105	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000119	0.00104	CcSEcCtD
Tacrolimus—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000118	0.00104	CcSEcCtD
Tacrolimus—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000117	0.00103	CcSEcCtD
Tacrolimus—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000117	0.00103	CcSEcCtD
Tacrolimus—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000113	0.000991	CcSEcCtD
Tacrolimus—PPP3CA—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000113	0.00528	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000112	0.000983	CcSEcCtD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00011	0.00513	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AGT—focal segmental glomerulosclerosis	0.00011	0.00513	CbGpPWpGaD
Tacrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFB1—focal segmental glomerulosclerosis	0.00011	0.00512	CbGpPWpGaD
Tacrolimus—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000109	0.000955	CcSEcCtD
Tacrolimus—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000109	0.00095	CcSEcCtD
Tacrolimus—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000109	0.00095	CcSEcCtD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000104	0.00484	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000102	0.00477	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000101	0.000886	CcSEcCtD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—PCNA—focal segmental glomerulosclerosis	9.97e-05	0.00466	CbGpPWpGaD
Tacrolimus—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	9.85e-05	0.000863	CcSEcCtD
Tacrolimus—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	9.71e-05	0.000851	CcSEcCtD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	9.63e-05	0.0045	CbGpPWpGaD
Tacrolimus—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	9.54e-05	0.00446	CbGpPWpGaD
Tacrolimus—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	9.39e-05	0.000823	CcSEcCtD
Tacrolimus—PPP3CA—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	9.3e-05	0.00435	CbGpPWpGaD
Tacrolimus—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	9.08e-05	0.000795	CcSEcCtD
Tacrolimus—FKBP1A—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	8.75e-05	0.00409	CbGpPWpGaD
Tacrolimus—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	8.73e-05	0.000764	CcSEcCtD
Tacrolimus—Rash—Cyclosporine—focal segmental glomerulosclerosis	8.66e-05	0.000758	CcSEcCtD
Tacrolimus—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	8.65e-05	0.000757	CcSEcCtD
Tacrolimus—Headache—Cyclosporine—focal segmental glomerulosclerosis	8.6e-05	0.000753	CcSEcCtD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—FN1—focal segmental glomerulosclerosis	8.48e-05	0.00396	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—CD79A—focal segmental glomerulosclerosis	8.17e-05	0.00382	CbGpPWpGaD
Tacrolimus—Nausea—Cyclosporine—focal segmental glomerulosclerosis	8.15e-05	0.000714	CcSEcCtD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	7.97e-05	0.00372	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	7.89e-05	0.00369	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—MYH9—focal segmental glomerulosclerosis	7.56e-05	0.00353	CbGpPWpGaD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—focal segmental glomerulosclerosis	7.47e-05	0.00349	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	7.21e-05	0.00337	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—SERPINE1—focal segmental glomerulosclerosis	7.06e-05	0.0033	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	7.05e-05	0.00329	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—PCNA—focal segmental glomerulosclerosis	7.05e-05	0.00329	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	7.01e-05	0.00328	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	6.9e-05	0.00322	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	6.6e-05	0.00308	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	6.54e-05	0.00306	CbGpPWpGaD
Tacrolimus—MTOR—CXCR4-mediated signaling events—MMP9—focal segmental glomerulosclerosis	6.46e-05	0.00302	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.38e-05	0.00298	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.34e-05	0.00296	CbGpPWpGaD
Tacrolimus—MTOR—Regulation of Telomerase—TGFB1—focal segmental glomerulosclerosis	6.31e-05	0.00295	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	6.18e-05	0.00289	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	6.07e-05	0.00283	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	5.91e-05	0.00276	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—MYH9—focal segmental glomerulosclerosis	5.66e-05	0.00265	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.33e-05	0.00249	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—focal segmental glomerulosclerosis	5.33e-05	0.00249	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	5.26e-05	0.00246	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	5.23e-05	0.00244	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	5.18e-05	0.00242	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.13e-05	0.00239	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	5.12e-05	0.00239	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	5.03e-05	0.00235	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	4.97e-05	0.00232	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	4.93e-05	0.00231	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	4.91e-05	0.00229	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	4.88e-05	0.00228	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	4.7e-05	0.0022	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	4.62e-05	0.00216	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD79A—focal segmental glomerulosclerosis	4.58e-05	0.00214	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—focal segmental glomerulosclerosis	4.45e-05	0.00208	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PIAS1—focal segmental glomerulosclerosis	4.45e-05	0.00208	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	4.4e-05	0.00206	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	4.31e-05	0.00201	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	4.27e-05	0.00199	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.14e-05	0.00193	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	4.11e-05	0.00192	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	3.99e-05	0.00187	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.97e-05	0.00186	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	3.86e-05	0.00181	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.77e-05	0.00176	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.75e-05	0.00175	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD40LG—focal segmental glomerulosclerosis	3.74e-05	0.00175	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.43e-05	0.0016	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—LPL—focal segmental glomerulosclerosis	3.38e-05	0.00158	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	3.32e-05	0.00155	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MYH9—focal segmental glomerulosclerosis	3.3e-05	0.00154	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	3.29e-05	0.00154	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.15e-05	0.00147	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.92e-05	0.00137	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.91e-05	0.00136	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.88e-05	0.00135	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.88e-05	0.00135	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	2.72e-05	0.00127	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	2.69e-05	0.00125	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	2.66e-05	0.00124	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	2.65e-05	0.00124	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NOS2—focal segmental glomerulosclerosis	2.64e-05	0.00124	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—LPL—focal segmental glomerulosclerosis	2.62e-05	0.00123	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	2.59e-05	0.00121	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.44e-05	0.00114	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.44e-05	0.00114	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	2.41e-05	0.00113	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	2.38e-05	0.00111	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.37e-05	0.00111	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	2.3e-05	0.00107	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.25e-05	0.00105	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	2.24e-05	0.00104	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.23e-05	0.00104	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.23e-05	0.00104	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—SERPINE1—focal segmental glomerulosclerosis	2.23e-05	0.00104	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.06e-05	0.000964	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS2—focal segmental glomerulosclerosis	2.05e-05	0.000958	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.03e-05	0.000948	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD79A—focal segmental glomerulosclerosis	2e-05	0.000934	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	1.99e-05	0.00093	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.97e-05	0.000919	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	1.91e-05	0.000893	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.89e-05	0.000885	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.87e-05	0.000875	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.84e-05	0.000859	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.81e-05	0.000844	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.74e-05	0.000813	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—SERPINE1—focal segmental glomerulosclerosis	1.73e-05	0.000807	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.64e-05	0.000768	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.63e-05	0.000764	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD40LG—focal segmental glomerulosclerosis	1.63e-05	0.000761	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	1.6e-05	0.000747	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.57e-05	0.000735	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.56e-05	0.000728	CbGpPWpGaD
Tacrolimus—MTOR—Disease—LPL—focal segmental glomerulosclerosis	1.48e-05	0.00069	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.45e-05	0.000679	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	1.41e-05	0.000658	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFB1—focal segmental glomerulosclerosis	1.41e-05	0.000657	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.37e-05	0.000642	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.36e-05	0.000637	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.3e-05	0.000606	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.26e-05	0.000587	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.21e-05	0.000565	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.21e-05	0.000564	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.19e-05	0.000558	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.19e-05	0.000555	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	1.18e-05	0.000553	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.17e-05	0.000547	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.17e-05	0.000545	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	1.16e-05	0.00054	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS2—focal segmental glomerulosclerosis	1.15e-05	0.000539	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFB1—focal segmental glomerulosclerosis	1.09e-05	0.000509	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.07e-05	0.000498	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.03e-05	0.000483	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	1.02e-05	0.000475	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	9.95e-06	0.000465	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	9.85e-06	0.00046	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.84e-06	0.00046	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.79e-06	0.000457	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	9.76e-06	0.000456	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SERPINE1—focal segmental glomerulosclerosis	9.71e-06	0.000454	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.37e-06	0.000438	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.26e-06	0.000433	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.84e-06	0.000413	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	8.76e-06	0.000409	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.72e-06	0.000407	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	8.35e-06	0.00039	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.17e-06	0.000382	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.07e-06	0.000377	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.68e-06	0.000359	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.63e-06	0.000357	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.46e-06	0.000349	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.07e-06	0.000331	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	7.05e-06	0.00033	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.8e-06	0.000318	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	6.41e-06	0.000299	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.22e-06	0.000291	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—focal segmental glomerulosclerosis	6.13e-06	0.000286	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	6.07e-06	0.000284	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	6.03e-06	0.000282	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	5.37e-06	0.000251	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	5.32e-06	0.000249	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.21e-06	0.000243	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	5.2e-06	0.000243	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	4.73e-06	0.000221	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	4.63e-06	0.000216	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	4.55e-06	0.000213	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.36e-06	0.000204	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.29e-06	0.000201	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	3.49e-06	0.000163	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	3.28e-06	0.000153	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.81e-06	0.000131	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	2.15e-06	0.000101	CbGpPWpGaD
